Nalaganje...

A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme

Many B cell cancers are characterized in part by the dysregulation of the NF-κB signaling pathway. A new study identifies somatic mutations in TNFAIP3, the gene encoding the NF-κB inhibitor A20, in Hodgkin lymphomas and primary mediastinal lymphomas. These data reveal the role of A20 as a tumor supp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Malynn, Barbara A., Ma, Averil
Format: Artigo
Jezik:Inglês
Izdano: The Rockefeller University Press 2009
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2715039/
https://ncbi.nlm.nih.gov/pubmed/19380636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20090765
Oznake: Označite
Brez oznak, prvi označite!